|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Selling and marketing | |||||
| Impairment expense | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on disposal of assets | |||||
| Other (expense) income | |||||
| Foreign exchange loss | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Unrealized (loss) gain, change in fair value of available-for-sale securities, net of tax | |||||
| Change in foreign currency translation | |||||
| Net loss and comprehensive loss | |||||
| Weighted average number of common shares - basic (in shares) | |||||
| Weighted average number of common shares - diluted (in shares) | |||||
| Loss per share - basic (in dollars per share) | |||||
| Loss per share - diluted (in dollars per share) | |||||
Loading...